Article Text
Articles
Correction: etodolac - a new NSAID (February 9, p.12)
Abstract
The article incorrectly described the trial by Jacob et al (ref 8) as a 2-week trial in which positive faecal occult blood tests were more frequent with etodolac than sulindac. In fact this trial lasted 12 weeks and more positive tests occurred on sulindac.